Servizi Italia Past Earnings Performance
Past criteria checks 1/6
Servizi Italia's earnings have been declining at an average annual rate of -4.2%, while the Healthcare industry saw earnings growing at 14.8% annually. Revenues have been growing at an average rate of 3% per year. Servizi Italia's return on equity is 3.3%, and it has net margins of 1.6%.
Key information
-4.2%
Earnings growth rate
-2.7%
EPS growth rate
| Healthcare Industry Growth | 16.7% |
| Revenue growth rate | 3.0% |
| Return on equity | 3.3% |
| Net Margin | 1.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Benign Growth For Servizi Italia S.p.A. (BIT:SRI) Underpins Its Share Price
Oct 09
Market Cool On Servizi Italia S.p.A.'s (BIT:SRI) Earnings
Feb 23Calculating The Intrinsic Value Of Servizi Italia S.p.A. (BIT:SRI)
Nov 11At €1.39, Is It Time To Put Servizi Italia S.p.A. (BIT:SRI) On Your Watch List?
Jan 28Servizi Italia S.p.A. (BIT:SRI) Shares Could Be 30% Above Their Intrinsic Value Estimate
Dec 16Here's Why Servizi Italia (BIT:SRI) Is Weighed Down By Its Debt Load
Oct 04Does This Valuation Of Servizi Italia S.p.A. (BIT:SRI) Imply Investors Are Overpaying?
Mar 14Servizi Italia S.p.A.'s (BIT:SRI) Intrinsic Value Is Potentially 22% Below Its Share Price
May 10Should You Think About Buying Servizi Italia S.p.A. (BIT:SRI) Now?
Apr 14Should You Buy Servizi Italia S.p.A. (BIT:SRI) For Its Dividend?
Mar 23What Type Of Returns Would Servizi Italia's(BIT:SRI) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Mar 04Servizi Italia (BIT:SRI) Seems To Be Using A Lot Of Debt
Feb 11A Look At The Fair Value Of Servizi Italia S.p.A. (BIT:SRI)
Jan 21What Is Servizi Italia S.p.A.'s (BIT:SRI) Share Price Doing?
Dec 31
Should You Buy Servizi Italia S.p.A. (BIT:SRI) For Its Dividend?
Dec 09Revenue & Expenses Breakdown
How Servizi Italia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 291 | 5 | 3 | 0 |
| 30 Jun 24 | 293 | 7 | 3 | 0 |
| 31 Mar 24 | 289 | 6 | 3 | 0 |
| 31 Dec 23 | 290 | 5 | 3 | 0 |
| 30 Sep 23 | 285 | 5 | 3 | 0 |
| 30 Jun 23 | 282 | 4 | 3 | 0 |
| 31 Mar 23 | 281 | 6 | 3 | 0 |
| 31 Dec 22 | 272 | 4 | 3 | 0 |
| 30 Sep 22 | 276 | 5 | 0 | 0 |
| 30 Jun 22 | 274 | 5 | 0 | 0 |
| 31 Mar 22 | 269 | 6 | 0 | 0 |
| 31 Dec 21 | 265 | 8 | 0 | 0 |
| 30 Sep 21 | 262 | 10 | 3 | 0 |
| 30 Jun 21 | 250 | 7 | 3 | 0 |
| 31 Mar 21 | 245 | 4 | 2 | 0 |
| 31 Dec 20 | 246 | 3 | 2 | 0 |
| 30 Sep 20 | 249 | 1 | 2 | 0 |
| 30 Jun 20 | 254 | 4 | 3 | 0 |
| 31 Mar 20 | 265 | 6 | 3 | 0 |
| 31 Dec 19 | 268 | 9 | 3 | 0 |
| 30 Sep 19 | 266 | 9 | 4 | 0 |
| 30 Jun 19 | 261 | 9 | 5 | 0 |
| 31 Mar 19 | 258 | 11 | 6 | 0 |
| 31 Dec 18 | 257 | 12 | 7 | 0 |
| 30 Sep 18 | 252 | 14 | 7 | 0 |
| 30 Jun 18 | 254 | 14 | 7 | 0 |
| 31 Mar 18 | 253 | 13 | 7 | 0 |
| 31 Dec 17 | 252 | 14 | 7 | 0 |
| 30 Sep 17 | 252 | 12 | 7 | 0 |
| 30 Jun 17 | 250 | 10 | 7 | 0 |
| 31 Mar 17 | 244 | 11 | 7 | 0 |
| 31 Dec 16 | 238 | 10 | 8 | 0 |
| 30 Sep 16 | 233 | 13 | 8 | 0 |
| 30 Jun 16 | 228 | 14 | 8 | 0 |
| 31 Mar 16 | 229 | 13 | 8 | 0 |
| 31 Dec 15 | 230 | 13 | 8 | 0 |
| 30 Sep 15 | 235 | 12 | 8 | 0 |
| 30 Jun 15 | 236 | 13 | 8 | 0 |
| 31 Mar 15 | 235 | 13 | 8 | 0 |
| 31 Dec 14 | 234 | 13 | 8 | 0 |
| 30 Sep 14 | 230 | 12 | 8 | 0 |
| 30 Jun 14 | 226 | 10 | 8 | 0 |
| 31 Mar 14 | 220 | 9 | 8 | 0 |
| 31 Dec 13 | 215 | 9 | 7 | 0 |
Quality Earnings: SRI has high quality earnings.
Growing Profit Margin: SRI's current net profit margins (1.6%) are lower than last year (1.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SRI's earnings have declined by 4.2% per year over the past 5 years.
Accelerating Growth: SRI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SRI had negative earnings growth (-8.6%) over the past year, making it difficult to compare to the Healthcare industry average (-8.6%).
Return on Equity
High ROE: SRI's Return on Equity (3.3%) is considered low.